Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 14.82% is 57% below its 5-year average of 34.71%, near the low end of its 5-year range (9.68%–159.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.91% below its 12-month average of 16.09%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.82%.
DEBT TO ASSETS RATIO
14.82%
DEBT TO ASSETS RATIO AVG TTM
16.09%
DEBT TO ASSETS RATIO AVG 3Y
17.21%
DEBT TO ASSETS RATIO AVG 5Y
34.71%
DEBT TO ASSETS RATIO AVG 10Y
44.34%
DEBT TO ASSETS RATIO AVG 15Y
38.98%
DEBT TO ASSETS RATIO AVG 20Y
34.30%
CURRENT VS TTM AVG
-7.91%
CURRENT VS 3Y AVG
-13.89%
CURRENT VS 5Y AVG
-57.32%
CURRENT VS 10Y AVG
-66.59%
CURRENT VS 15Y AVG
-62.00%
CURRENT VS 20Y AVG
-56.81%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+16361.34%
vs the sector median at left
TherapeuticsMD, Inc.
Market Cap
$23.15M
Debt to Assets Ratio
14.82%
TTM Avg
16.09%
3Y Avg
17.21%
5Y Avg
34.71%
Market Cap
$22.90M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.18M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.90M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.84M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.64M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$20.99M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | $23.15M | 14.82% | 16.09% | 17.21% | 34.71% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.90M | 0.00% | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.64M | 0.01% | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.01M | 0.00% | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.18M | 0.09% | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 0.17% | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $21.84M | 0.02% | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.64M | 0.00% | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | 0.07% | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $20.47M | 0.19% | N/A | N/A | N/A |
Debt/Assets
14.8%
Debt/Equity
0.20
Current Ratio
3.22
Interest Coverage
-526.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 14.82% |
| 2026-03-31 | 15.52% |
| 2025-12-31 | 16.19% |
| 2025-09-30 | 16.76% |
| 2025-06-30 | 17.15% |
| 2025-03-31 | 18.23% |
| 2024-12-31 | 18.48% |
| 2024-09-30 | 18.71% |
| 2024-06-30 | 18.92% |
| 2024-03-31 | 18.54% |
| 2023-12-31 | 18.48% |
| 2023-09-30 | 16.25% |
| 2023-06-30 | 15.62% |
| 2023-03-31 | 14.39% |
| 2022-12-31 | 9.68% |
| 2022-09-30 | 76.57% |
| 2022-06-30 | 68.32% |
| 2022-03-31 | 159.04% |
| 2021-12-31 | 116.65% |
| 2021-09-30 | 93.00% |
| 2021-06-30 | 91.95% |
| 2021-03-31 | 80.44% |
| 2020-12-31 | 136.90% |
| 2020-09-30 | 140.09% |
| 2020-06-30 | 124.17% |
| 2020-03-31 | 94.54% |
| 2019-12-31 | 77.18% |
| 2019-09-30 | 81.56% |
| 2019-06-30 | 79.73% |
| 2019-03-31 | 41.91% |
| 2018-12-31 | 34.62% |
| 2018-09-30 | 30.94% |
| 2018-06-30 | 42.55% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.23% |
| 2012-12-31 | 61.69% |
| 2012-09-30 | 159.08% |
| 2012-06-30 | 72.64% |
| 2012-03-31 | 239.30% |
| 2011-12-31 | 149.44% |
| 2011-09-30 | 4974.79% |
| 2011-06-30 | 5666.61% |
| 2011-03-31 | 24044.27% |
| 2010-12-31 | 161.21% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 95.25% |
| 2009-12-31 | 70.61% |
| 2009-09-30 | 43.48% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 4.60% |
| 2006-06-30 | 5.01% |
| 2006-03-31 | 5.38% |
| 2005-12-31 | 4.53% |
| 2005-09-30 | 4.17% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
